๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer
NCT04384601Gastric Cancer, Neoadjuvant Chemotherapy
Ruijin Hospital
Phase 3
246
Shanghai
2021-09
Not yet open
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasโ„ข BRS System
NCT04995159Coronary Heart Disease
Lepu Medical Technology (Beijing) Co., Ltd.
Not applicable
2,150
Bengbu, Hefei, Wuhu, Beijing, Chongqing, Lanzhou, Foshan, Guangzhou
2021-09
Recruiting
SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
NCT05445154Newly Diagnosed Acute Myeloid Leukemia (AML)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1/2
58
Chengdu
2021-08-31
Recruiting
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
NCT05316805Atopic Dermatitis Eczema, Prurigo Nodularis
Peking University First Hospital
Observational
100,000
Beijing
2021-08-31
Active, closed
PRL3-Zumab in Patients With Advanced Solid Tumors
NCT07541001Advanced Malignant Solid Tumor
Intra-IMMUSG Pte Ltd
Phase 2
60
Hangzhou
2021-08-30
Recruiting
R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden
NCT05040555Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3B
oubai, MD/PhD
Not applicable
64
Changchun
2021-08-30
Recruiting
Precise Diagnosis, Treatment and Prognostic Evaluation of Complicated Adrenal Tumor Diseases
NCT04529629Complicated Adrenal Tumor Diseases
Shanghai Jiao Tong University School of Medicine
Observational
1,000
Shanghai
2021-08-30
Active, closed
To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis
NCT04957550Psoriatic Arthritis
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
418
Beijing
2021-08-30
Active, closed
Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor Patients
NCT04821895Gastrointestinal Stromal Tumor (GIST)
National Health Research Institutes, Taiwan
Observational
50
2021-08-28
Active, closed
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
NCT04961996Early Breast Cancer
Hoffmann-La Roche
Phase 3
4,170
Zhengzhou, Changsha, Nanchang, Changchun, Shanghai, Chengdu, Hangzhou, Beijing
2021-08-27
Recruiting
Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer
NCT05201430Rectal Cancer
Fudan University
Phase 3
300
Shanghai
2021-08-27
Active, closed
A Study of AK104 Plus Platinum-containing ChemotherapyยฑBevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
NCT04982237Cervical Cancer
Akeso
Phase 3
445
Hangzhou, Hefei, Shanghai
2021-08-27
Recruiting
Application of CT-Linac-Based "All-in-One" One-Stop Radiotherapy in Breast Cancer
NCT07776301Breast Cancer
Fudan University
Not applicable
225
Shanghai
2021-08-27
Recruiting
Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study
NCT05372263Pulmonary Hypertension
China National Center for Cardiovascular Diseases
Observational
700
Beijing
2021-08-26
Active, closed
Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer
NCT04922853Rectal Cancer, Neoadjuvant Chemotherapy
West China Hospital
Phase 3
554
Wuxi, Chengdu, Kunming
2021-08-26
Active, closed
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
NCT04807166Ovarian Neoplasms, Fallopian Tube Neoplasms, Neoplasms by Site, Genital Neoplasms, Female
Wenjun Cheng
Phase 2
56
Huai'an, Nanjing, Suzhou, Wuxi, Yancheng
2021-08-24
Recruiting
Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer
NCT05010681Intrahepatic Cholangiocarcinoma
Fudan University
Phase 2
25
Shanghai
2021-08-24
Recruiting
A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
NCT04982276Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
Akeso
Phase 1/2
138
Beijing
2021-08-23
Active, closed
A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP
NCT05023915Immune Thrombocytopenia
Shandong University
Phase 2
106
Jinan, Qingdao
2021-08-21
Recruiting
Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients With Taxanes-induced Painful Peripheral Neuropathy
NCT04970121Chemotherapy-induced Peripheral Neuropathy, Pain, Solid Tumor
Yan Yang, MD, Ph.D
Phase 2
100
Bengbu
2021-08-21
Active, closed
Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases
NCT06611657Whole Brain Radiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
40
Beijing
2021-08-20
Active, closed
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
NCT04849728NASH - Nonalcoholic Steatohepatitis
Inventiva Pharma
Phase 3
1,000
Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Shenzhen, Nanning
2021-08-19
Active, closed
Multi-centre Study to Evaluate ACAF Versus Laminoplasty in Treating Cervical Ossification of the Posterior Longitudinal Ligament
NCT04968028Ossification of Posterior Longitudinal Ligament, Cervical Spondylosis With Myelopathy
Shanghai Changzheng Hospital
Not applicable
167
Beijing, Shenzhen, Harbin, Jining, Qingdao, Shanghai, Taiyuan, Xiโ€™an
2021-08-17
Active, closed
A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
NCT04974398Nasopharyngeal Carcinoma
Akeso
Phase 3
296
Hefei, Fuzhou, Xiamen, Dongguan, Guangzhou, Jiangmen, Shantou, Shenzhen
2021-08-16
Recruiting
Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition
NCT04436965Nasopharyngeal Carcinoma, Nutrition Therapy
Sun Yat-sen University
Phase 3
266
Guangzhou
2021-08-16
By invitation
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
NCT04957719Acute Myocardial Infarction
Viatris Innovation GmbH
Phase 3
25,000
Baotou, Beijing, Cangzhou, Changchun, Changsha, Chengdu, Chongqing, Dalian
2021-08-14
Recruiting
Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC
NCT05011487Non-Small Cell Lung Cancer
Sun Yat-sen University
Phase 2
30
Guangzhou
2021-08-13
Active, closed
A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia
NCT04980885Acute Myeloid Leukemia
Akeso
Phase 1/2
68
Hangzhou
2021-08-13
Recruiting
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2ฮฑ Related Genetic Alterations (MK-6482-015)
NCT04924075Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease, Advanced Gastrointestinal Stromal Tumor
Merck Sharp & Dohme LLC
Phase 2
355
Beijing, Guangzhou, Shanghai, Chengdu
2021-08-12
Active, closed
Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine
NCT04946734PFO - Patent Foramen Ovale, Migraine
Guangdong Provincial People's Hospital
Phase 3
440
Xiamen, Guangzhou, Huizhou, Jiangmen, Shenzhen, Zhanjiang, Nanning, Shangqiu
2021-08-12
Active, closed
Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR Mutations
NCT04923906Non-small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 3
624
Shanghai
2021-08-11
Recruiting
ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors
NCT04891198Solid Tumor
3D Medicines (Sichuan) Co., Ltd.
Phase 2
126
Beijing
2021-08-06
Recruiting
Neural Mechanisms of Cognitive Assessment and Rehabilitation for Cognitive Decline
NCT05014893Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD), Aging, Healthy
National Research Center for Rehabilitation Technical Aids
Not applicable
100
Beijing
2021-08-06
By invitation
IT Matters: The Erectile Restoration Registry
NCT04200937Erectile Dysfunction
Boston Scientific Corporation
Observational
450
Beijing, Shanghai
2021-08-05
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Pierre Fabre Medicament
Phase 1
400
Haerbin, Linyi, Beijing, Shanghai
2021-08-04
Recruiting
Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer
NCT05218889Pancreatic Cancer, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreas Cancer, Pancreatic Neoplasms
Chinese PLA General Hospital
Phase 1/2
90
Beijing
2021-08-04
Recruiting
Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer
NCT04974346Cervical Cancer
Zhejiang Cancer Hospital
Phase 3
455
Hangzhou, Jinhua, Lishui, Ningbo, Taizhou, Wanzhou
2021-08-02
Recruiting
Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL)
NCT04989621Follicular Lymphoma, Relapsed and Refractory Follicular Lymphoma
Sun Yat-sen University
Phase 2
32
Guangzhou
2021-08-01
Recruiting
Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index
NCT05728268Breast Cancer
Shantou Central Hospital
Phase 2
64
Shantou
2021-08-01
Recruiting
Closed-loop Functional Spinal Cord Stimulation in Patients With Spinal Cord Injury
NCT04969042Spinal Cord Injuries
Luming Li
Phase 1
10
Beijing
2021-08-01
Recruiting
The Brain Mechanism of Social Emotion and Communication in Infants Aged 0 to 6 Years
NCT05040542Brain Development, Behavior Disorders, Child, Intellectual Developmental Disorders
Children's Hospital of Fudan University
Observational
3,001
Xiamen
2021-08-01
By invitation
Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1)
NCT06101940Myotonic Dystrophy 1
Huashan Hospital
Observational
1,000
Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Wuhan, Nanjing, Suzhou
2021-08-01
Recruiting
Clinical Study of Desuzumab in the Treatment of Knee Osteoarthritis
NCT06357741Knee Osteoarthritis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
30
Wuhan
2021-08-01
Not yet open
Neurological Sequelae in Patients With Acute Carbon Monoxide Poisoning
NCT04925297Carbon Monoxide Poisoning
The First Hospital of Jilin University
Observational
1,250
Changchun
2021-08-01
Recruiting
Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients
NCT04983121Breast Neoplasms
Shengjing Hospital
Phase 2
30
Shenyang
2021-08-01
Recruiting
The Efficacy and Safety of the Bispecific Anti-PD-1/PD-L1 Antibody IBI318 Combined with Lenvatinib in NSCLC.
NCT04777084Non-Small Cell Lung Cancer
Hunan Province Tumor Hospital
Phase 2
120
Changsha
2021-08-01
Active, closed
PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma
NCT04907370Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
532
Beijing, Chongqing, Foshan, Guangzhou, Nanning, Guiyang, Wuhan, Changsha
2021-08-01
Not yet open
Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy
NCT04973319Breast Cancer
Shengjing Hospital
Phase 3
450
Shenyang
2021-08-01
By invitation
FHND9041 Versus Afatinib for Non-small Cell Lung Cancer
NCT06759857Non Small Cell Lung Cancer
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Phase 3
350
Beijing
2021-08-01
By invitation
Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection
NCT04762459Non-small Cell Lung Carcinoma
Chinese Academy of Medical Sciences
Phase 3
606
Beijing, Changsha, Chendu, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou
2021-08-01
Not yet open
Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)
NCT04846634Resectable Locally Advanced Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
90
Nanchang
2021-08
Recruiting
Immunoinflammatory Regulation of Esketamine in Septic Patients
NCT04843982Esketamine, Sepsis, Inflammatory Response, Immunosuppression
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4
100
Wuhan
2021-07-28
Active, closed
A Phase โ…ข Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions
NCT04914598Malignant Pleural Effusion
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 3
290
Nanjing
2021-07-28
Recruiting
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
NCT04817618C3G
Novartis Pharmaceuticals
Phase 3
98
Guangzhou, Wuhan, Beijing, Shanghai
2021-07-28
Active, closed
China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
NCT06868654Multiple Myeloma
GlaxoSmithKline
Phase 3
72
Beijing, Changchun, Guangzhou, Hangzhou, Jinan, Nanjing, Shenyang, Suzhou
2021-07-28
Active, closed
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT04747613Paroxysmal Nocturnal Hemoglobinuria
Novartis Pharmaceuticals
Phase 3
208
Beijing, Tianjin
2021-07-27
By invitation
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
NCT04976322Systemic Lupus Erythematosus
UCB Biopharma SRL
Phase 3
760
Beijing, Changchun, Guangzhou, Guilin, Shanghai, Suzhou, Tianjin, Wenzhou
2021-07-27
Recruiting
Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma
NCT05008965Allergic Asthma
Oneness Biotech Co., Ltd.
Phase 2
100
2021-07-27
Active, closed
A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation in China
NCT05009329NSCLC, Solid Tumor
Allist Pharmaceuticals, Inc.
Phase 1/2
315
Beijing
2021-07-26
By invitation
The GUARDIAN Trial - Induction Agent Sub-Study
NCT04934683Major Surgery
The University of Texas Health Science Center, Houston
Phase 4
6,254
Shanghai, Beijing, Sichuan
2021-07-25
Recruiting
The GUARDIAN Trial
NCT04884802Blood Pressure
The University of Texas Health Science Center, Houston
Not applicable
6,254
Beijing, Chengdu, Hong Kong, Shanghai, Xuzhou
2021-07-25
By invitation
The GUARDIAN Trial - Vasopressor Sub-Study
NCT04934748Blood Pressure
The University of Texas Health Science Center, Houston
Phase 4
6,254
Beijing, Shanghai, Sichuan
2021-07-25
Active, closed
the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration
NCT05126446Aortic Dissection
Lifetech Scientific (Shenzhen) Co., Ltd.
Not applicable
120
Changsha
2021-07-25
Active, closed
Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer
NCT04906993Cervical Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
443
Shanghai
2021-07-23
Recruiting
Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma
NCT04997837Gastric Cancer
Fudan University
Phase 3
433
Shanghai
2021-07-21
Active, closed
Newly Diagnosed Glioblastoma
NCT04959500Glioblastoma
Sun Yat-sen University
Phase 2
150
Bengbu, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Shenzhen, Zhuhai
2021-07-21
Active, closed
Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)
NCT04928807Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3
231
Wuhan
2021-07-20
Recruiting
Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer โ‰ค 2 cm in the Middle Third of the Lung Field
NCT04944563Lung Neoplasms, Surgery
The First Affiliated Hospital with Nanjing Medical University
Not applicable
1,120
Nanjing
2021-07-20
Active, closed
Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)
NCT05712902Non-Small Cell Lung Cancer
Dizal Pharmaceuticals
Phase 2
104
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Haikou, Hangzhou
2021-07-19
Recruiting
Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma
NCT04888429Sarcomatoid Carcinoma of Lung
Qian Chu
Phase 2
28
Xiamen, Zhengzhou, Wuhan, Changsha, Jinan
2021-07-19
Recruiting
Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer
NCT04136782Breast Cancer
Shengjing Hospital
Phase 4
110
Harbin, Changchun, Dalian, Panjin, Shenyang
2021-07-19
Recruiting
Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT
NCT04137653Breast Cancer
Shengjing Hospital
Phase 3
1,498
Shenyang
2021-07-19
Recruiting
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy
NCT04476485Breast Cancer
Shengjing Hospital
Observational
1,000
Harbin, Changchun, Dalian, Panjin, Shenyang
2021-07-19
Active, closed
Evolut PRO China Clinical Study
NCT04982588Severe, Symptomatic Aortic Stenosis
Medtronic Cardiovascular
Not applicable
52
Beijing, Chengdu, Hangzhou
2021-07-17
Active, closed
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
NCT04961567Lupus Erythematosus, Systemic
Biogen
Phase 3
562
Beijing, Dongguan, Guangzhou, Shenzhen, Haikou, Changsha, Zhuzhou, Wuhan
2021-07-16
Active, closed
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naรฏve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFฮฑ Inhibitor Treatment
NCT04908189Psoriatic Arthritis
Bristol-Myers Squibb
Phase 3
729
Bengbu, Beijing, Guangzhou, Shenzhen, Zhengzhou, Changsha, Changzhou, Nanjing
2021-07-15
Recruiting
Efficacy of Prophylactic Epinephrine Solution Injection in Prevention of Delayed Post-sphincterotomy
NCT04964869Bleeding Hemorrhage
Wen-Hsin Huang
Not applicable
400
2021-07-15
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
NCT04951622Myasthenia Gravis
Janssen Research & Development, LLC
Phase 3
199
Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Jinan
2021-07-15
Recruiting
TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma
NCT04954781Intrahepatic Cholangiocarcinoma
Fudan University
Phase 2
25
Shanghai
2021-07-14
Active, closed
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer
NCT04898634Prostatic Neoplasms
Janssen Research & Development, LLC
Phase 1
216
Beijing, Chongqing, Guangzhou, Wenzhou
2021-07-13
Active, closed
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naรฏve to Biologic Disease-modifying Anti-rheumatic Drugs
NCT04908202Psoriatic Arthritis
Bristol-Myers Squibb
Phase 3
670
Hefei, Beijing, Chongqing, Guangzhou, Shenzhen, Dalian, Shanghai, Yiwu
2021-07-13
Active, closed
Phase II Neoadjuvant Pyrotinib Combined With Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial
NCT05165225Breast Cancer, HER2-low-expressing Breast Cancer, Hormone Receptor-positive Breast Cancer, Neoadjuvant Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
48
Guangzhou
2021-07-13
Recruiting
International Headache Registry Study
NCT05418218Headache Disorders, Primary, Headache Disorders, Secondary, Migraine, Tension-Type Headache
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
200,000
Hangzhou
2021-07-12
Active, closed
PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST
NCT06979921Cancer
The First Affiliated Hospital with Nanjing Medical University
Observational
496
Nanjing, Qingdao
2021-07-10
Recruiting
Enteral Nutrition in Infants With Ileostomy
NCT04707443Nutrition of Ileostomy Infants
Children's Hospital of Fudan University
Observational
110
Shanghai
2021-07-08
Recruiting
Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)
NCT04807140Head and Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
57
Guangzhou
2021-07-08
Recruiting
Knee-Hip-Spine Harmony: The Relationship Between Sagittal Spinal Alignment in Total Hip/Knee Arthroplasty
NCT05685706Cases Who Received TKA/THA
China Medical University Hospital
Observational
300
2021-07-07
By invitation
A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China
NCT04989751LGMD, LGMDR2, LGMDR1
Huashan Hospital
Observational
450
Shanghai
2021-07-07
Recruiting
A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma
NCT04993690B-cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 1
200
Beijing, Guangzhou
2021-07-06
Recruiting
Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension
NCT04753840Hypertension
Henan Institute of Cardiovascular Epidemiology
Not applicable
400
Zhengzhou
2021-07-03
Recruiting
Diagnosis and Treatment of Foreign Bodies Outside Pharynx and Esophagus Lumen
NCT04917367Surgery
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
50
Hangzhou
2021-07-02
Recruiting
Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer
NCT05292742Breast Cancer, Adjuvant Therapy
Fujian Medical University Union Hospital
Phase 2
206
Fuzhou
2021-07-02
Recruiting
Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial
NCT04948749ICAD - Intracranial Atherosclerotic Disease, ICAS - Intracranial Atherosclerosis, Drug-eluting Stent, Stroke
Beijing Tiantan Hospital
Not applicable
358
Beijing, Cangzhou, Tangshan, Xingtai, Wuhan, Baotou, Hohhot, Tongliao
2021-07-02
Active, closed
Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients
NCT04538911Tuberculosis
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Phase 1
60
Shenzhen
2021-07-02
Active, closed
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
NCT04886804Neoplasm Metastasis, Non-Small Cell Lung Cancer
Boehringer Ingelheim
Phase 1
554
Beijing, Changchun, Fuzhou, Guangzhou, Hangzhou, Harbin, Nanning, Shanghai
2021-07-02
Recruiting
ENMS With Balance Feedback for Post-stroke Ankle-foot Rehabilitation
NCT04934787Cerebrovascular Stroke, Foot Drop, Foot Inversion Deformity
The Hong Kong Polytechnic University
Not applicable
60
Hong Kong
2021-07-01
Recruiting
Baduanjin Training for Depression and Anxiety Patients
NCT05589337Depression Symptoms, Anxiety Symptoms
Shanghai University of Traditional Chinese Medicine
Not applicable
120
Shanghai
2021-07-01
Active, closed
Characteristics of Vaginal and Intestinal Microbiota and Cervical HPV Infection
NCT05003505Intestinal Microbiota, Vaginal Microbiota, HPV Infection
Fujian Maternity and Child Health Hospital
Observational
651
Fuzhou, Ningde, Quanzhou, Xiamen, Zhangzhou, Foshan, Shenzhen, Wuhan
2021-07-01
Recruiting
EyeConic: Qualification for Cone-Optogenetics
NCT05294978Retinal Dystrophies
Institute of Molecular and Clinical Ophthalmology Basel
Observational
1,000
Beijing
2021-07-01
Recruiting
Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET
NCT03859921Subfertility
The University of Hong Kong
Phase 3
716
Hong Kong
2021-07-01
Rows per page Showing 17301–17400 of 19052
Previous 172 173 174 175 176 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=174

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.